1. Home
  2. VREX vs KALV Comparison

VREX vs KALV Comparison

Compare VREX & KALV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Varex Imaging Corporation

VREX

Varex Imaging Corporation

HOLD

Current Price

$11.89

Market Cap

483.7M

Sector

Technology

ML Signal

HOLD

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$15.19

Market Cap

551.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VREX
KALV
Founded
2016
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
483.7M
551.2M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
VREX
KALV
Price
$11.89
$15.19
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
6
Target Price
$16.67
$27.17
AVG Volume (30 Days)
283.5K
1.4M
Earning Date
02-05-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$844,600,000.00
$1,426,000.00
Revenue This Year
$4.79
N/A
Revenue Next Year
$4.15
$204.16
P/E Ratio
N/A
N/A
Revenue Growth
4.14
N/A
52 Week Low
$6.76
$7.30
52 Week High
$15.46
$17.30

Technical Indicators

Market Signals
Indicator
VREX
KALV
Relative Strength Index (RSI) 52.12 50.69
Support Level $11.71 $14.70
Resistance Level $12.54 $16.30
Average True Range (ATR) 0.32 0.86
MACD 0.04 -0.22
Stochastic Oscillator 41.82 14.62

Price Performance

Historical Comparison
VREX
KALV

About VREX Varex Imaging Corporation

Varex Imaging Corp designs and manufactures X-ray imaging components. It operates in two segments Medical and Industrial. The Medical segment, which is the key revenue driver, designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, digital detectors and accessories, generators, and heat exchangers among other products. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital flat panel detectors, high-voltage connectors, and coolers. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA) and the rest from the Americas and Asia Pacific region.

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

Share on Social Networks: